SVB Wealth’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,616
| Closed | -$297K | – | 1064 |
|
|
2021
Q2 | $297K | Buy |
1,616
+272
| +20% | +$50K | ﹤0.01% | 760 |
|
|
2021
Q1 | $206K | Sell |
1,344
-76
| -5% | -$11.6K | ﹤0.01% | 827 |
|
|
2020
Q4 | $221K | Buy |
+1,420
| New | +$221K | ﹤0.01% | 721 |
|
|
2016
Q2 | – | Sell |
-6,495
| Closed | -$904K | – | 527 |
|
|
2016
Q1 | $904K | Sell |
6,495
-591
| -8% | -$82.3K | 0.04% | 269 |
|
|
2015
Q4 | $1.35M | Sell |
7,086
-2,757
| -28% | -$526K | 0.05% | 240 |
|
|
2015
Q3 | $1.54M | Sell |
9,843
-74
| -0.7% | -$11.6K | 0.06% | 239 |
|
|
2015
Q2 | $1.79M | Sell |
9,917
-1,131
| -10% | -$204K | 0.06% | 243 |
|
|
2015
Q1 | $1.92M | Sell |
11,048
-887
| -7% | -$154K | 0.06% | 239 |
|
|
2014
Q4 | $2.21M | Buy |
+11,935
| New | +$2.21M | 0.07% | 222 |
|